#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Meningitis meningococcal Idiopathic inflammatory myopathy Neurofibromatosis Noonan syndrome Arrhythmogenic right ventricular dysplasia Chronic cutaneous lupus erythematosus B-cell small lymphocytic lymphoma Angiosarcoma Retinoblastoma Vitamin B12 deficiency Congenital aplastic anaemia Medulloblastoma Glioblastoma CDKL5 deficiency disorder Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I Behcet’s syndrome – Life with Disease Synovial sarcoma metastatic – Treatment Isodicentric chromosome 15 syndrome – Treatment Leiomyosarcoma – Basic Information Cystic fibrosis – Basic Information Pulmonary sarcoidosis Systemic mastocytosis – Life with Disease Castleman’s disease – Trials in Disease Gaucher’s disease type I – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somatostatin Alglucosidase Alfa Aluminium Oxide Magnesium Oxybate Pertechnetate (99Mtc) Sodium Spartalizumab Perflubutane Lolium Perenne Amniotic Membrane, Human MB-001 USNOFLAST Adct-402 Lasmiditan Zinc Sulphate Heptahydrate Pramipexole Cobicistat TETANUS TOXOID Poloxamer 407 ZAMPILIMAB Pemetrexed Disodium More therapies…

    Learn about Your Condition

    Brain neoplasm malignant Knee arthroplasty External cephalic version Bile acid synthesis disorder Ovarian cancer stage III Encephalitis Japanese B Tuberculosis Haemorrhoids Haemorrhage prophylaxis Bipolar I disorder Astrocytoma malignant Angiopathy Myasthenia gravis Type IIa hyperlipidaemia Hyperglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Obinutuzumab and Mycophenolate Mofetil Without Oral Corticosteroids for Treatment of Lupus Nephritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Azathioprine
    • Mycophenolate Mofetil
    France

  • Study on the Effect of Ropivacaine Hydrochloride and Sodium Chloride on Recovery After Inguinal Hernia Surgery for Patients Undergoing Open Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Inguinal hernia
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    Finland

  • Study on the Effects of 7% Hypertonic Saline Inhalation and ELTGOL Physiotherapy for Patients with Bronchiectasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Mannitol
    • Sodium Chloride Ph. Eur.
    Spain

  • Study on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer’s Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Dimethyl Fumarate
    Poland

  • Study of Pembrolizumab Combined with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma Multiforme Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    Poland

  • Study of Asciminib treatment for patients with Chronic Myeloid Leukemia who have T315I mutation and cannot take or tolerate ponatinib

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Asciminib Hydrochloride
    France
Previous Page
1 … 405 406 407 408 409 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!